
How AI Is Helping Psychiatrists Make Faster, Smarter Treatment Decisions
Clinical trials, real-world data and digital biomarkers are turning artificial intelligence into a practical ally in the fight against depression.
Clinical trials, real-world data and digital biomarkers are turning artificial intelligence into a practical ally in the fight against depression.
More precise and consumer-friendly biomarker detection technologies are coming to market at a pace that can help users gain rich insight into their health and well-being from anywhere and at any time. This is especially important when it comes to preventive healthcare.
Digital biomarkers today serve as a valuable monitoring tool, providing details about a patient’s general health and response to treatment. But, as technology continues to develop, they could fuel predictive insights about a patient’s future health outcomes and disease trajectory, as well as demonstrate measurable quality of life improvements.
There's still a gap between potential and validation when it comes to digital biomarkers.